Enhancing the Benefits of Antiretroviral Therapy in Vietnam: Towards Ending AIDS

Current HIV/AIDS Reports

Volumn 11, Issue 4, 2014, Pages 487-495

  Kato, Masaya ^a   Long, Nguyen Hoang ^b   Duong, Bui Duc ^b   Nhan, Do Thi ^b   Nguyen, Thi Thuy Van ^a   Hai, Nguyen Huu ^b   Giang, Le Minh ^c   Hoa, Do Mai ^d   Van, Nguyen Thanh ^e   Suthar, Amitabh B ^a   Fontaine, Chris ^e   Nadol, Patrick ^f   Lo, Ying Ru ^a   McConnell, Michelle S ^f  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b MINISTRY OF HEALTH   (Viet Nam)

^c HANOI MEDICAL UNIVERSITY   (Viet Nam)

^d HANOI UNIVERSITY OF PUBLIC HEALTH   (Viet Nam)

^e UNAIDS Vietnam   (Viet Nam)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antiretroviral therapy; Concentrated epidemic; HIV prevention; People who inject drugs; Vietnam

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOL ABUSE; CD4 LYMPHOCYTE COUNT; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEPRESSION; EPIDEMIC; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INVESTMENT; MATHEMATICAL MODEL; OPIATE SUBSTITUTION TREATMENT; PATIENT COUNSELING; PILOT STUDY; PREVALENCE; PRIMARY HEALTH CARE; REVIEW; SCALE UP; SEXUALITY; SOCIAL INSURANCE; SOCIAL MARKETING; TOTAL QUALITY MANAGEMENT; TUBERCULOSIS; VIET NAM; VIRUS LOAD; ECONOMICS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; PATHOGENICITY; THEORETICAL MODEL;

ANTI-RETROVIRAL AGENTS; HIV; HIV INFECTIONS; HUMANS; MODELS, THEORETICAL; VIETNAM;

EID: 84919493014     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-014-0235-7     Document Type: Review

References (45)

1. Viet Nam Authority of HIV/AIDS Control. Viet Nam HIV/AIDS estimates and projections 2011–2015. Hanoi, Viet Nam: Ministry of Health; 2012.
2. National committee for AIDS, drugs and prostitution prevention and control. Vietnam AIDS response progress report 2014. Hanoi, Viet Nam: Government of Vietnam; 2014.
3. Family Health International. Results of the program evaluation of patients initiating antiretroviral therapy in two health facilities in Ho Chi Minh City, Viet Nam. Hanoi, Viet Nam; 2010.
4. Nguyen DB et al. Outcomes of antiretroviral therapy in Vietnam: results from a national evaluation. PLoS ONE. 2013;8(2):e55750.
5. World Health Organization. Good practice in Asia: targeted HIV prevention for IDU and sex workers. Vietnam's first large-scale national harm reduction initiative WHO/WPRO and partners. Hanoi, Vietnam; 2010.
6. Viet Nam Authority of HIV/AIDS Control, HIV/STI Integrated biological and behavioral surveillance (IBBS) in Viet Nam 2009. 2012.
7. Viet Nam Authority of HIV/AIDS Control. Viet Nam HIV/AIDS estimates and projections 2014–2020. Hanoi, VietNam: Ministry of Health; 2014.
8. The Office of the Global AIDS Coordinator. PEPFAR blueprint: creating an AIDS-free generation. Washington D.C., U.S.A; 2012.
9. Anglemyer A et al. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev. 2011;10(8):CD009153.
10. Attia S et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23(11):1397–404.
11. Cohen MS et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.
12. Kato M et al. The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: towards elimination of HIV transmission. J Acquir Immune Defic Syndr. 2013;63(5):e142–9.
13. Eaton JW et al. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Global Health. 2014;2:e23–34.
14. Granich R et al. Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011–2050. PLoS ONE. 2012;7(2):e30216.
15. Granich RM et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48–57.
16. Wood E et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338:b1649.
17. Kirk, G., et al. Decline in community viral load strongly associated with declining HIV incidence among IDU. in 18th Conference on Retroviruses and Opportunistic Infections. 2011. Boston, MA, USA.
18. Bruce RD. Is it time for treatment as prevention among people who inject drugs? J Acquir Immune Defic Syndr. 2013;63(5):545–7.
19. National Committee for AIDS, Drugs and prostitution prevention and control. Viet Nam AIDS response progress report 2012. Hanoi, Viet Nam; 2012.
20. Nguyen, T.T.M., et al. Monitoring and strengthening linkage from HIV diagnosis to care enrollment through province-wide tracking system in Thanh Hoa province, Viet Nam. (Abstract no. TUPE754). in 19th International AIDS Conference. 2012. Washington D.C., U.S.A.
21. Nguyen, T.M.T., et al. Outcome of Pre-ART and ART management at 83 sites in 51 provinces in Viet Nam. in The 11th International Congress on AIDS in Asia and the Pacific. 2013. Bangkok, Thailand.
22. Pham, T.L., et al. Methadone treatment can promotes earlier ARV treatment and care retention among IDUs in Vietnam. in 11th International Congress on AIDS in Asia and the Pacific. 2013. Bangkok, Thailand.
23. World Health Organization. Global update on HIV treatment 2013: results, impact and opportunities. Geneva, Switzerland; 2013.
24. Do TN et al. Combining cohort analysis and monitoring of HIV early-warning indicators of drug resistance to assess antiretroviral therapy services in Vietnam. Clin Infect Dis. 2012;54 Suppl 4:S306–12.
25. Nguyen, T.M.T., et al. Outcome of pre-ART care and ART retention at 62 ART sites in 36 provinces in Viet Nam (Abstract no. WEPE122). in 19th International AIDS Conference. 2012. Washington D.C., U.S.A.
26. Do HM et al. Factors associated with suboptimal adherence to antiretroviral therapy in Viet Nam: a cross-sectional study using audio computer-assisted self-interview (ACASI). BMC Infect Dis. 2013;13(1):154.
27. Do DC et al. Monitoring the efficacy of antiretroviral therapy by a simple reverse transcriptase assay in HIV‑infected adults in rural Vietnam. Futur Virol. 2012;7:923–31.
28. Nguyen HT et al. HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam. Antivir Ther. 2008;13 Suppl 2:115–21.
29. Tanuma, J., et al., Low prevalence of transmitted drug resistance of HIV-1 during 2008–2012 antiretroviral therapy scaling up in Southern Vietnam. J Acquir Immune Defic Syndr, 2014.
30. Duc NB et al. Surveillance of transmitted HIV drug resistance using matched plasma and dried blood spot specimens from voluntary counseling and testing sites in Ho Chi Minh City, Vietnam, 2007–2008. Clin Infect Dis. 2012;54 Suppl 4:S343–7.
31. Hong NT et al. Utilization of HIV voluntary counseling and testing in Viet Nam: an evaluation of 5 years of routine program data for national response. AIDS Educ Prev. 2011;23(3 Suppl):30–48.
32. Vietnam National Network of People Living with HIV. PLHIV Stigma Index. 2012, Hanoi, Vietnam.
33. Do, T.N., et al. Immediate antiretroviral therapy among serodiscordant couples for treatment and prevention: Experiences in two provinces in Vietnam. in 20th International AIDS Conference. 2014. Melbourne, Australia.
34. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. Geneva, Switzerland; 2013.
35. World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. Geneva, Switzerland; 2014.
36. Global Network of People Living with HIV. GNP + Position Paper: ART for Prevention. 2012.
37. Hirnschall, G. and B. Schwartlander, Treatment 2.0: catalysing the next phase of scale-up. Lancet, 2011.
38. Bui, D.D., et al. Promoting expanded and earlier access to HIV treatment: Treatment 2.0 in Vietnam. in 20th International AIDS conference. 2014. Melbourne, Australia.
39. Bui DD et al. Treatment 2.0 Pilot in Viet Nam—early progress and challenges. World J AIDS. 2012;2:64–70.
40. Duong AT et al. Costing analysis of national HIV treatment and care program in Vietnam. J Acquir Immune Defic Syndr. 2014;65(1):e1–7.
41. Government of Vietnam. Prime Minister's Decision on approval of the Project on sustainable financing for HIV/AIDS prevention and control activities in 2013–2020 period. Hanoi, Vietnam; 2013.
42. World Health Organization. Delivering HIV test results and messages for re-testing and counselling in adults. Geneva, Switzerland; 2010.
43. World Health Organization. Service delivery approaches to HIV testing and counselling (HTC): A strategic policy framework. Geneva, Switzerland; 2012.
44. Maher L, Coupland H, Musson R. Scaling up HIV treatment, care and support for injecting drug users in Vietnam. Int J Drug Policy. 2007;18(4):296–305.
45. World Health Organization. Assessment of compulsory treatment of people who use drugs in Cambodia, China, Malaysia and Viet Nam: an application of selected human rights principles. Manila, Philippines ; 2009.